Back to Search
JARED ROBL, MD
MD
Cardiovascular Disease Physician
NPI: 1730746801Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
R-11485(IA)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
MD-49855(IA)
Research & Publications (20)
Normal development following chromatin transfer correlates with donor cell initial epigenetic state.
PMID 19632072·Anim Reprod Sci·2010
7-preclinical
Antigen-specific human polyclonal antibodies from hyperimmunized cattle.
PMID 19151699·Nat Biotechnol·2009
7-preclinical
Transcriptional reprogramming of gene expression in bovine somatic cell chromatin transfer embryos.
PMID 19393066·BMC Genomics·2009
4-observational
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
PMID 18485702·Bioorg Med Chem Lett·2008
8-other
Commercialising genetically engineered animal biomedical products.
PMID 18154699·Reprod Fertil Dev·2008
6-review
(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
PMID 18554903·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).
PMID 18288793·J Med Chem·2008
7-preclinical
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.
PMID 18295486·Bioorg Med Chem Lett·2008
7-preclinical
Tetrazole based amides as growth hormone secretagogues.
PMID 18378446·Bioorg Med Chem Lett·2008
7-preclinical
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
PMID 18282707·Bioorg Med Chem Lett·2008
7-preclinical
A synthesis of N-bridged 5,6-bicylic pyridines via a mild cyclodehydration using the burgess reagent and discovery of a novel carbamylsulfonylation reaction.
PMID 18533675·Org Lett·2008
8-other
The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statins.
PMID 17986646·J Pharmacol Exp Ther·2008
4-observational
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.
PMID 18412317·J Med Chem·2008
7-preclinical
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.
PMID 17937986·Bioorg Med Chem Lett·2007
4-observational
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
PMID 17554340·Nature·2007
7-preclinical
Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).
PMID 17585753·J Med Chem·2007
7-preclinical
Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment.
PMID 17656086·Bioorg Med Chem Lett·2007
7-preclinical
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors.
PMID 17855089·Bioorg Med Chem Lett·2007
8-other
Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
PMID 17869100·Bioorg Med Chem Lett·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 HAWKINS DR
IOWA CITY, IA 52242 - Phone
- (319) 384-8001
Quick Facts
- NPI
- 1730746801
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile